ALDH7A1 and asthma: Currently, a large number of preclinical in vivo studies on PDE inhibitors exhibit decreased cell recruitment, activation of inflammatory cells and physiological changes in lung function in asthma, chronic obstructive pulmonary disease, and others [70,71].